Mayo Clinic: Rotavirus vaccine given to newborns in Africa is effective

Public release date: 17-Jun-2013
[ | E-mail | Share ]

Contact: Bob Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic

Vaccine may save thousands of lives annually

ROCHESTER, Minn. -- Mayo Clinic and other researchers have shown that a vaccine given to newborns is at least 60 percent effective against rotavirus in Ghana. Rotavirus causes fever, vomiting and diarrhea, which in infants can cause severe dehydration. In developed nations, the condition often results in an emergency room visit or an occasional hospitalization, but is rarely fatal. In developing countries, however, rotavirus-related illness causes approximately 500,000 deaths per year. The findings appear this week in the Journal of Infectious Diseases.

Currently, there is no neonatal rotavirus vaccine available and infants do not receive their first dose of a rotavirus vaccine until they are approximately 2 months old, leaving younger infants at serious risk of rotavirus infection. In the study, the first of two doses was administered within the first 29 days of life (neonatal dosing), and the second dose before 60 days of age.

"For the first time in a large-scale study, we have demonstrated that protection against rotavirus gastroenteritis can be achieved earlier in life," says co-author and pediatrician Robert M. Jacobson, M.D., of the Mayo Clinic Children's Center. "The next step should be additional studies in neonates to provide earlier protection against life-threatening rotavirus diarrhea. The rotavirus vaccines used in America and Europe are administered later -- when babies are 2 to 4 months old -- but younger infants also contract the virus in the first two months of life."

Two vaccines serve as standard protection in developed countries, but are not especially effective in African or Asian countries, says Dr. Jacobson. Besides, he says, protection is also needed from birth due to the widespread risk of the virus.

"There is a huge protection gap right now in the first months of life," says Dr. Jacobson. "This study points to a clear and practical solution."

In Ghana, 998 newborns were selected for the randomized, double-blind, placebo trial from two of the poorest parts of the country. Half received the oral reassortant rotavirus tetravalent vaccine (RRV-TV) in the first two months of life, half received a placebo. Results showed a significant response in parameters of efficacy, safety and immune impact of the vaccine.

###

The study was funded by the International Medical Foundation. Co-authors include George Armah, Ph.D., University of Ghana; Albert Kapikian, M.D., National Institutes of Health; Timo Vesikari, M.D., Ph.D., University of Tampere, Finland; Nigel Cunliffe, M.D., Ph.D., University of Liverpool, U.K.; D. Bruce Burlington, M.D., Gaithersburg, Md.; and Leonard Ruiz Jr., Ph.D., International Medica Foundation, Rochester.

About Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.org/about and http://www.mayoclinic.org/news.

Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.

MULTIMEDIA ALERT: Video of Dr. Jacobson is available on the Mayo Clinic News Network.

---

[ | E-mail | Share ]

?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Public release date: 17-Jun-2013
[ | E-mail | Share ]

Contact: Bob Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic

Vaccine may save thousands of lives annually

ROCHESTER, Minn. -- Mayo Clinic and other researchers have shown that a vaccine given to newborns is at least 60 percent effective against rotavirus in Ghana. Rotavirus causes fever, vomiting and diarrhea, which in infants can cause severe dehydration. In developed nations, the condition often results in an emergency room visit or an occasional hospitalization, but is rarely fatal. In developing countries, however, rotavirus-related illness causes approximately 500,000 deaths per year. The findings appear this week in the Journal of Infectious Diseases.

Currently, there is no neonatal rotavirus vaccine available and infants do not receive their first dose of a rotavirus vaccine until they are approximately 2 months old, leaving younger infants at serious risk of rotavirus infection. In the study, the first of two doses was administered within the first 29 days of life (neonatal dosing), and the second dose before 60 days of age.

"For the first time in a large-scale study, we have demonstrated that protection against rotavirus gastroenteritis can be achieved earlier in life," says co-author and pediatrician Robert M. Jacobson, M.D., of the Mayo Clinic Children's Center. "The next step should be additional studies in neonates to provide earlier protection against life-threatening rotavirus diarrhea. The rotavirus vaccines used in America and Europe are administered later -- when babies are 2 to 4 months old -- but younger infants also contract the virus in the first two months of life."

Two vaccines serve as standard protection in developed countries, but are not especially effective in African or Asian countries, says Dr. Jacobson. Besides, he says, protection is also needed from birth due to the widespread risk of the virus.

"There is a huge protection gap right now in the first months of life," says Dr. Jacobson. "This study points to a clear and practical solution."

In Ghana, 998 newborns were selected for the randomized, double-blind, placebo trial from two of the poorest parts of the country. Half received the oral reassortant rotavirus tetravalent vaccine (RRV-TV) in the first two months of life, half received a placebo. Results showed a significant response in parameters of efficacy, safety and immune impact of the vaccine.

###

The study was funded by the International Medical Foundation. Co-authors include George Armah, Ph.D., University of Ghana; Albert Kapikian, M.D., National Institutes of Health; Timo Vesikari, M.D., Ph.D., University of Tampere, Finland; Nigel Cunliffe, M.D., Ph.D., University of Liverpool, U.K.; D. Bruce Burlington, M.D., Gaithersburg, Md.; and Leonard Ruiz Jr., Ph.D., International Medica Foundation, Rochester.

About Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.org/about and http://www.mayoclinic.org/news.

Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.

MULTIMEDIA ALERT: Video of Dr. Jacobson is available on the Mayo Clinic News Network.

---

[ | E-mail | Share ]

?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Source: http://www.eurekalert.org/pub_releases/2013-06/mc-mcr061713.php

lakers Marcus Lattimore Tyrann Mathieu nfl draft grades Jon Jones Broken Toe matt barkley russell westbrook

Quality of waking hours determines ease of falling sleep

Public release date: 17-Jun-2013
[ | E-mail | Share ]

Contact: Deborah Wormser
deborah.wormser@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center

DALLAS June 17, 2013 The quality of wakefulness affects how quickly a mammal falls asleep, UT Southwestern Medical Center researchers report in a study that identifies two proteins never before linked to alertness and sleep-wake balance.

"This study supports the idea that subjective sleepiness is influenced by the quality of experiences right before bedtime. Are you reluctantly awake or excited to be awake?" said Dr. Masashi Yanagisawa, professor of molecular genetics and a Howard Hughes Medical Institute investigator at UT Southwestern. He is principal author of the study published online in May in the Proceedings of the National Academy of Sciences.

Co-author Dr. Robert Greene, UT Southwestern professor of psychiatry and a physician at the Dallas VA Medical Center, said the study is unique in showing that the need for sleep (called sleep homeostasis) can be separated from wakefulness both behaviorally and biochemically, meaning the two processes can now be studied individually.

"Two of the great mysteries in neuroscience are why do we sleep and what is sleep's function? Separating sleep need from wakefulness and identifying two different proteins involved in these steps represents a fundamental advance," he said.

If borne out by further research, this study could lead to new ways of assessing and possibly treating sleep disorders, perhaps by focusing more attention on the hours before bedtime because the quality of wakefulness has a profound effect on sleep, Dr. Yanagisawa said.

The experiment featured three groups of mice with virtually identical genes. The control group slept and woke at will and followed the usual mouse pattern of sleeping during the day and being awake at night. The two test groups were treated the same and had the same amount of sleep delay six hours but they were kept awake in different ways, said lead author Dr. Ayako Suzuki, a postdoctoral researcher who works in the laboratories of both Dr. Yanagisawa and Dr. Greene.

The first test group's sleep was delayed by a series of cage changes. Mice are intensely curious, so each cage change was followed by an hour spent vigorously exploring the new surroundings. This behavior would roughly correspond to teenagers voluntarily delaying bedtime with a new and stimulating event like a rock concert or video game.

Researchers kept the second group awake as gently as possible, usually by waving a hand in front of the cage or tapping it lightly whenever the mice appeared to be settling down to sleep. That test group would more resemble parents reluctantly staying awake awaiting a child's return from a concert.

Both test groups experienced the same amount of sleep deprivation, but their reactions to the different forms of alertness were striking, Dr. Yanagisawa said. In one test, the cage-changing group took longer to fall asleep than the gentle-handling group even though an analysis of their brain waves indicated equal amounts of sleep need in both test groups.

"The need to sleep is as high in the cage-changing group as in the gentle-handling group, but the cage-changers didn't feel sleepy at all. Their time to fall asleep was nearly the same as the free-sleeping, well-rested control group," he said.

The researchers identified two proteins that affected these responses, each linked to different aspects of sleep: phosphorylated dynamin 1 levels were linked to how long it took to fall asleep, while phosphorylated N-myc downstream regulated gene 2 protein levels tracked the amount of sleep deprivation and corresponded to the well-known brain-wave measure of sleep need, they report.

"The two situations are different biochemically, which is a novel finding," Dr. Yanagisawa said, adding, "These proteins are completely new to sleep research and have never before been linked to sleep need and wakefulness."

From an evolutionary perspective, an arousal mechanism that adapts to environmental stimuli is crucial because sleeping on a rigid schedule could be dangerous. "Animals, including humans, must be able to keep themselves at least temporarily alert, say during a natural disaster," he said.

###

Drs. Yanagisawa and Greene are both corresponding authors on the study, and both have dual appointments at the International Institute for Integrative Sleep Medicine, University of Tsukuba, Tsukuba, Japan. Former Associate Professor of Internal Medicine Dr. Christopher M. Sinton, now at the University of Arizona, was also involved in the study.

The study was funded by the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology; the Perot Family Foundation; and the Department of Veterans Affairs.

About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty includes many distinguished members, including five who have been awarded Nobel Prizes since 1985. Numbering more than 2,700, the faculty is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in 40 specialties to nearly 90,000 hospitalized patients and oversee more than 1.9 million outpatient visits a year.

This news release is available on our home page at http://www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via email,
subscribe at http://www.utsouthwestern.edu/receivenews

---

[ | E-mail | Share ]

?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Public release date: 17-Jun-2013
[ | E-mail | Share ]

Contact: Deborah Wormser
deborah.wormser@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center

DALLAS June 17, 2013 The quality of wakefulness affects how quickly a mammal falls asleep, UT Southwestern Medical Center researchers report in a study that identifies two proteins never before linked to alertness and sleep-wake balance.

"This study supports the idea that subjective sleepiness is influenced by the quality of experiences right before bedtime. Are you reluctantly awake or excited to be awake?" said Dr. Masashi Yanagisawa, professor of molecular genetics and a Howard Hughes Medical Institute investigator at UT Southwestern. He is principal author of the study published online in May in the Proceedings of the National Academy of Sciences.

Co-author Dr. Robert Greene, UT Southwestern professor of psychiatry and a physician at the Dallas VA Medical Center, said the study is unique in showing that the need for sleep (called sleep homeostasis) can be separated from wakefulness both behaviorally and biochemically, meaning the two processes can now be studied individually.

"Two of the great mysteries in neuroscience are why do we sleep and what is sleep's function? Separating sleep need from wakefulness and identifying two different proteins involved in these steps represents a fundamental advance," he said.

If borne out by further research, this study could lead to new ways of assessing and possibly treating sleep disorders, perhaps by focusing more attention on the hours before bedtime because the quality of wakefulness has a profound effect on sleep, Dr. Yanagisawa said.

The experiment featured three groups of mice with virtually identical genes. The control group slept and woke at will and followed the usual mouse pattern of sleeping during the day and being awake at night. The two test groups were treated the same and had the same amount of sleep delay six hours but they were kept awake in different ways, said lead author Dr. Ayako Suzuki, a postdoctoral researcher who works in the laboratories of both Dr. Yanagisawa and Dr. Greene.

The first test group's sleep was delayed by a series of cage changes. Mice are intensely curious, so each cage change was followed by an hour spent vigorously exploring the new surroundings. This behavior would roughly correspond to teenagers voluntarily delaying bedtime with a new and stimulating event like a rock concert or video game.

Researchers kept the second group awake as gently as possible, usually by waving a hand in front of the cage or tapping it lightly whenever the mice appeared to be settling down to sleep. That test group would more resemble parents reluctantly staying awake awaiting a child's return from a concert.

Both test groups experienced the same amount of sleep deprivation, but their reactions to the different forms of alertness were striking, Dr. Yanagisawa said. In one test, the cage-changing group took longer to fall asleep than the gentle-handling group even though an analysis of their brain waves indicated equal amounts of sleep need in both test groups.

"The need to sleep is as high in the cage-changing group as in the gentle-handling group, but the cage-changers didn't feel sleepy at all. Their time to fall asleep was nearly the same as the free-sleeping, well-rested control group," he said.

The researchers identified two proteins that affected these responses, each linked to different aspects of sleep: phosphorylated dynamin 1 levels were linked to how long it took to fall asleep, while phosphorylated N-myc downstream regulated gene 2 protein levels tracked the amount of sleep deprivation and corresponded to the well-known brain-wave measure of sleep need, they report.

"The two situations are different biochemically, which is a novel finding," Dr. Yanagisawa said, adding, "These proteins are completely new to sleep research and have never before been linked to sleep need and wakefulness."

From an evolutionary perspective, an arousal mechanism that adapts to environmental stimuli is crucial because sleeping on a rigid schedule could be dangerous. "Animals, including humans, must be able to keep themselves at least temporarily alert, say during a natural disaster," he said.

###

Drs. Yanagisawa and Greene are both corresponding authors on the study, and both have dual appointments at the International Institute for Integrative Sleep Medicine, University of Tsukuba, Tsukuba, Japan. Former Associate Professor of Internal Medicine Dr. Christopher M. Sinton, now at the University of Arizona, was also involved in the study.

The study was funded by the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology; the Perot Family Foundation; and the Department of Veterans Affairs.

About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty includes many distinguished members, including five who have been awarded Nobel Prizes since 1985. Numbering more than 2,700, the faculty is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in 40 specialties to nearly 90,000 hospitalized patients and oversee more than 1.9 million outpatient visits a year.

This news release is available on our home page at http://www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via email,
subscribe at http://www.utsouthwestern.edu/receivenews

---

[ | E-mail | Share ]

?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Source: http://www.eurekalert.org/pub_releases/2013-06/usmc-qow061713.php

brandon rios oklahoma news nascar news doppler radar colorado rockies moonshine news channel 4

The Safety Valve Of Dividend Growth Investing - Seeking Alpha

In the past five or so years, there have been five prominent dividend growth companies that experienced dividend cuts (or worse) which realistically could have been a part of a conservative dividend growth investor's portfolio.

(1) There was the collapse of Wachovia. What made this so unfortunate is that Wachovia had been a conservatively run bank with $40 per share in book value that drained its liquidity during the mid 2000s when business was booming, and did not have the cash and cash equivalent resources to weather the storm that erupted in 2008.

(2) There was the collapse at Bank of America (BAC). The banking giant, which had spent most of the 20th century burnishing its reputation as a financial fortress (I'm referring here to the pre-merger California arm of the bank), overextended itself on leverage while conducting acquisitions, and caused permanent harm to shareholders through its excessive share count dilution and acquisition of Countrywide during the financial crisis. The quarterly dividend was cut from $0.64 per share to $0.01 per share.

(3) And then there was the dividend cut at Wells Fargo (WFC). This was more a reflection of political reality (pressure from the Fed, as Warren Buffett explained in his 2010 Letter to Shareholders) than it was a reflection of the company's long-term earnings power. Nevertheless, the company's quarterly dividend was cut from $0.34 to $0.05 per share.

(4) And, of course, there was the granddaddy cut of them all: General Electric (GE). GE had been the ultimate conservative retiree stock. It was an original member of the Dow. Alongside AT&T (T), GE spent the 20th century living up to its reputation as the ultimate widow-and-orphan stock. Despite assurances from management that GE Capital posed no material threat to GE's dividend, a liquidity crisis drove the Board of Directors to conserve capital and cut the quarterly dividend from $0.31 per share to $0.10 per share.

(5) And lastly, we have BP (BP) and its oil spill. BP had become the UK's version of Exxon Mobil (XOM), becoming an inevitable member of pension funds, trust funds, and index funds throughout Britain. At its height, BP contributed over 10% of the total income to the British pension system. The weight on that company's shoulders (for retirees) was awesome in every sense of that word. Facing political pressure, BP cut its dividend from $0.84 to nothing for three straight quarters, at which point the company began paying a $0.42 quarterly dividend in the first quarter of 2011.

Even if you owned all five stocks in your conservative income portfolio, you still could have navigated those waters all right thanks to diversification and the dividend growth of other firms in your portfolio.

Here is how it could have played out. Let us say that you had ownership stakes in thirty different companies, each of which contributed $200 on average to your portfolio's total income. Together, they generated $6,000 in total income.

Let us say that before the crisis hit your portfolio, the five companies listed above contributed $1,000 total towards your portfolio's income (i.e. $1,000 worth of the $6,000 total). In the case of Wachovia, Bank of America, and BP, the income was effectively reduced to $0 (with the Wachovia reduction being basically permanent, the BP reduction being temporary, and with the Bank of America reduction being likely temporary). That is about $600 in lost income.

In the case of GE, the dividend became 32.25% of what it was before the cut. So the $200 in GE dividends was reduced to $64.50 in annual income. In the case of Wells Fargo, the dividend became 14.70% of what it was before the crisis. That means that $200 worth of Wells Fargo dividends became $29.41 in annual income.

So when you sum it up, you saw $1,000 worth of annual income turn into $93.91 worth of annual income.

Now, here is where things get interesting: You can still come out quite okay when you own a diversified portfolio of blue-chip stocks because the dividend growth rate of your other firms can offset some loss of income. The best kept secret among those executing a dividend growth strategy is the fact that it is relatively easy to get a 10% increase in annual income from a high-quality dividend growth stock if you choose to reinvest the dividends.

Let me use Johnson & Johnson (JNJ) as an example. The Board of Directors gave shareholders an increase in the quarterly dividend from $0.61 to $0.66 per share. To most people keeping score at home, that may sound like just a 8.19% annual dividend increase. But if you are reinvesting your dividends along the way, your year-over-year income will increase at a faster rate than the declared dividend increase.

Let us look at a real world example with Johnson & Johnson over the past year. On June 13th, 2012, Johnson & Johnson shareholders received a $0.61 per share dividend that could have gotten reinvested at $64.26 per share. On September 12th, 2012, J&J shareholders received a $0.61 per share dividend that got reinvested at a price of $68.23 per share. On December 12th, 2012, J&J shareholders received a $0.61 per share dividend that got reinvested at a price of $71.27 per share. And on March 13th, 2013, investors received a $0.61 per share dividend that got reinvested at a price of $78.43.

Let's look at how that would have played out in reality for someone with 100 shares of Johnson & Johnson. During the first $61 payout, our investor would have 100.94 shares of J&J. The second payment would be for $61.57, which would increase the total to 101.84 total shares. The third $0.61 quarterly payment would generate $62.12 worth of income, which would bring the total share count to 102.71 shares. And during the last $0.61 quarterly payout, the J&J investor would have received $62.65, bringing his share count total to 103.50 shares. Those extra 3.5 shares are what add "the kick" to the next dividend increase.

When the Johnson & Johnson board raised the dividend to $0.66 per share, the share count base is 103.50 (instead of 100) if you chose to reinvest your dividends over the previous year. Instead of getting a $66 payout, you are getting a $68.31 payout. Converted into percentage terms, although it appears that Johnson & Johnson gave shareholders an increase of 8.19%, shareholders that elected to reinvest their dividends actually received an annual income increase of 11.98%.

This is why 10% annual increases in income are not rosy fantasyland projections for dividend growth investors. When you have companies like Coca-Cola (KO), Johnson & Johnson, and Procter & Gamble (PG) in your portfolio that are giving you regular dividend increases of around 8%, you can pick up that extra 2% and get to a 10% increase in annual income simply by clicking the "reinvest dividends" button on your brokerage website.

This is why a dividend investor can make some mistakes along the way and still do all right for himself. You could lose your dividend soldiers named General Electric, Wachovia, BP, Wells Fargo, and Bank of America and still win the war. If the other twenty-five stocks in your portfolio give you a year-over-year income increase of 10% (7.5-8% of that coming from an organic increase, and the other 2-2.5% coming from reinvested dividends), then you could see the $5,000 in your portfolio income grow to $5,500. It is a countervailing force against the stocks in your portfolio that did cut the dividend.

When you add it all up, look at what resulted from the carnage: you had five stocks turn $1,000 worth of income into $93.91. But if the rest of your portfolio was filled with the "usual suspects" of the dividend growth investor's universe, then you saw that $5,000 in income grow into $5,500. When you tally it all up, you saw $6,000 worth of annual income turn into $5,593 in annual income. In our worst case scenario, you are looking at a pay cut of 7%.

Now let's highlight the layers of conservatism that were used as inputs in our assumptions. First of all, we are assuming you owned each of the five companies listed above in your portfolio. Secondly, they were treated as if these cuts happened instantaneously to your portfolio, even though they occurred over a course of three years in reality. And thirdly, our assumptions basically treat BP as a "dead" stock, even though its dividend came back to life three quarters later. In the case of GE and Wells Fargo, the current quarterly dividends have since risen to $0.19 and $0.30, respectively. And Bank of America's dividend will likely show signs of life in the coming years as well.

This is what serves as the safety valve of a dividend growth investing strategy. The stocks that give you 7-8% annual dividend increases can bolster your income against dividend cuts, and if you choose to reinvest those dividends, you can realistically achieve 10% annual income gains from that portion of your portfolio's holdings. This allows you to tolerate failure in other areas of your portfolio without missing much of a beat. Even if you managed to own Bank of America, BP, Wachovia, General Electric, and Wells Fargo, you could have realistically limited your total annual income loss to 7% if you maintained a diversified portfolio and reinvested the dividends of your other holdings. Considering that we are talking about holding five burnout companies during the worst economic period since The Great Depression, that ain't bad.

Disclosure: I am long BAC, XOM, BP, PG, GE, JNJ. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More...)

Source: http://seekingalpha.com/article/1503872-the-safety-valve-of-dividend-growth-investing

best picture 2012 oscar winners channel 3 news j lo j lo sacha baron cohen ryan seacrest octavia spencer

Chinese activist says he's being forced out by NYU

BEIJING (AP) ? A Chinese dissident who was allowed to travel to the U.S. after escaping from house arrest says New York University is forcing him and his family to leave at the end of this month because of pressure from the Chinese government.

Chen Guangcheng said in a statement Monday that China's Communist Party had been applying "great, unrelenting pressure" on NYU to ask him to leave.

NYU spokesman John Beckman rejected Chen's allegations about Beijing's influence on Chen's fellowship at the university, calling his claims "false and contradicted by the well-established facts."

Chen sparked a diplomatic crisis between China and the U.S. last year when he fled to the U.S. Embassy in Beijing from house arrest. Since last May, he'd been a special student at NYU's U.S.-Asia Law institute.

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/cae69a7523db45408eeb2b3a98c0c9c5/Article_2013-06-16-China-US-Blind%20Activist/id-7bc58ec3379e4dbd9e2b828488ac65d8

Paige Butcher David Petraeus Petraeus Mia Love wall street journal us map Electoral Map

Kim Kardashian Gives Birth To Baby Girl

Boyfriend Kanye West gets surprise early Father's Day gift as baby reportedly arrives five weeks early.
By MTV News staff

Kanye West and Kim Kardashian
Photo: Getty Images

Source: http://www.mtv.com/news/articles/1709103/kim-kardashian-gives-birth.jhtml

Lemon phillies phillies bryce harper dodgers Kevin Ware Google Nose

Gisele Bundchen Launches Her New Lingerie Line in Brazil | Gisele ...

Gisele Bundchen sports a sheer shirt at the launch of her new lingerie line Gisele Bundchen Intimates held at a shopping mall on Sunday (June 16) in Sao Paulo, Brazil.

The 32-year-old Brazilian supermodel posed for photos with fans and showed off her amazing new collection.

PHOTOS: Check out the latest pics of Gisele Bundchen

?Launching my new collection Gisele B?ndchen Intimates? she tweeted.

Earlier in the week, Gisele was spotted chatting on the phone while out shopping with a gal pal in Boston, Mass.

30+ pictures inside of Gisele Bundchen launching her new line of lingerie?

Like Just Jared on Facebook

Source: http://www.justjared.com/2013/06/16/gisele-bundchen-launches-her-new-lingerie-line-in-brazil/

between two ferns statins chardon sean young juan pablo montoya free pancakes at ihop martina navratilova

Access Hollywood section

Sorry, Readability was unable to parse this page for content.

Source: http://www.today.com/id/7358550/ns/today-entertainment/

Dancing With The Stars All Stars Joseph Gordon-Levitt space shuttle Torrey Smith Brother fiona apple CJ Spiller tracy morgan